Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506154 · ClinicalTrials.gov registry record · Phase 3
Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder
A Phase 3 study, sponsored by MEDRx USA.
- Completed
- Registry status
- Phase 3
- Development phase
- 210
- Enrollment target
NCT01506154 is a Phase 3 study that has completed, run by MEDRx USA. The registered enrollment target is 210 participants.
The verdict
NCT01506154, a Phase 3 study, has completed, sponsored by MEDRx USA.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 210 participants
- Enrollment target
Study Summary
A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of the Shoulder.
Interventions
- DRUG MRX-7EAT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2011-12 |
| Est. Completion | 2012-10 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01506154
The ClinicalTrials.gov registry entry for NCT01506154 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 210 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MEDRx USA, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRX-7EAT is the first listed.
NCT01506154 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01506154 about?
NCT01506154 is a clinical study titled "Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder". A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Pain due to Recent Onset Supraspinatous and/or Subacromial Tendonitis/Bursitis and/or Subdeltoid Bursitis of...
What is the current status of trial NCT01506154?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 210 participants. The study started on 2011-12. Estimated completion is 2012-10.
What interventions are being tested in trial NCT01506154?
The interventions under investigation include: MRX-7EAT (DRUG).
Who is sponsoring clinical trial NCT01506154?
This trial is sponsored by MEDRx USA, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.